J&J/Cordis Acquisition Ensures Place In Vascular Closure Arena

Cordis expects to initiate clinical trials in early 2007 for a bioabsorbable femoral artery closure device acquired through its purchase of Ensure Medical, announced July 13

More from Archive

More from Medtech Insight